Pieris Pharmaceuticals, Inc.
NASDAQ:PIRS
16.16 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 17.396 | 38.635 | 117.764 | 70.436 | 62.26 | 74.867 | 37.878 | 29.356 | 29.349 | 18.474 | 3.689 | 6.327 |
| Short Term Investments
| 8.97 | 20.534 | 0 | 0 | 41.894 | 53.24 | 34.751 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 26.366 | 59.169 | 117.764 | 70.436 | 104.154 | 128.107 | 72.629 | 29.356 | 29.349 | 18.474 | 3.689 | 6.327 |
| Net Receivables
| 6.039 | 5.81 | 3.313 | 1.706 | 6.787 | 2.701 | 15.546 | 0.058 | 0.981 | 0.015 | 0.548 | 0.971 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.981 | 0 | 0.072 | 0 |
| Other Current Assets
| 6.275 | 8.445 | 6.548 | 3.579 | 4.072 | 4.574 | 1.615 | 3.26 | 2.311 | 1.316 | 0.51 | 0.567 |
| Total Current Assets
| 38.68 | 73.424 | 127.625 | 75.721 | 115.013 | 135.382 | 89.79 | 32.673 | 31.661 | 19.805 | 4.82 | 7.865 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 0 | 20.697 | 23.031 | 25.98 | 22.938 | 5.049 | 4.034 | 2.264 | 2.163 | 2.052 | 2.438 | 2.674 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 9.922 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.027 | 0.019 | 0 |
| Other Non-Current Assets
| 0 | 1.369 | 2.904 | 3.309 | 3.146 | 0.91 | 0.13 | 0.126 | 0.127 | 0 | 0 | -2.674 |
| Total Non-Current Assets
| 0 | 22.066 | 25.935 | 29.289 | 26.084 | 5.959 | 14.086 | 2.39 | 2.29 | 2.079 | 2.457 | 2.674 |
| Total Assets
| 38.68 | 95.49 | 153.56 | 105.01 | 141.097 | 141.341 | 103.876 | 35.063 | 33.95 | 21.884 | 7.277 | 10.57 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 3.372 | 4.154 | 8.609 | 3.007 | 10.054 | 3.35 | 2.452 | 2.386 | 1.059 | 1.26 | 0.278 | 0.814 |
| Short Term Debt
| 0 | 0.859 | 1.049 | 1.03 | 0.733 | 0 | 4.862 | 0 | 0 | 1.271 | 0.206 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0.128 | 0.522 | 0.378 | 0.424 | 0.455 | 0.179 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 20.824 | 25.116 | 12.627 | 11.256 | 35.612 | 37.153 | 2.275 | 0 | 0.77 | 0.545 | 0 |
| Other Current Liabilities
| 8.55 | 10.746 | 15.787 | 5.481 | 4.96 | 9.114 | 1.308 | 3.719 | 1.739 | 0.243 | 0.739 | 8.44 |
| Total Current Liabilities
| 11.922 | 36.583 | 50.561 | 22.145 | 27.003 | 48.076 | 45.775 | 8.38 | 2.798 | 3.544 | 1.768 | 9.253 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 0 | 12.244 | 13.841 | 15.932 | 15.484 | 0 | 0 | 0 | 0 | 0 | 4.544 | 0 |
| Deferred Revenue Non-Current
| 0 | 18.734 | 38.403 | 35.9 | 47.258 | 53.303 | 46.542 | 1.409 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | -18.734 | -38.403 | 0 | -47.258 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 18.734 | 38.403 | 0.006 | 47.258 | 0.027 | 0.037 | 0.047 | 0.024 | 0.334 | 0.38 | 0 |
| Total Non-Current Liabilities
| 0 | 30.978 | 52.244 | 51.838 | 62.742 | 53.33 | 46.579 | 1.456 | 0.024 | 0.334 | 4.924 | 0 |
| Total Liabilities
| 11.922 | 67.561 | 102.805 | 73.983 | 89.745 | 101.406 | 92.354 | 9.836 | 2.822 | 3.878 | 6.692 | 9.253 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.215 |
| Common Stock
| 0.098 | 0.074 | 0.072 | 0.056 | 0.055 | 0.054 | 0.045 | 0.043 | 0.04 | 0.029 | 0.012 | 0.054 |
| Retained Earnings
| -314.964 | -290.421 | -257.144 | -211.406 | -174.176 | -147.066 | -120.312 | -102.665 | -79.866 | -65.807 | -55.957 | -56.023 |
| Accumulated Other Comprehensive Income/Loss
| 0.028 | -0.254 | 0.829 | -0.295 | -1.995 | -2.982 | -4.695 | -1.501 | -1.273 | -0.843 | -0.956 | 0 |
| Other Total Stockholders Equity
| 341.596 | 318.53 | 306.998 | 242.672 | 227.468 | 189.929 | 136.484 | 129.35 | 112.227 | 84.627 | 57.487 | 55.25 |
| Total Shareholders Equity
| 26.758 | 27.929 | 50.755 | 31.027 | 51.352 | 39.935 | 11.522 | 25.227 | 31.128 | 18.006 | 0.585 | 0.496 |
| Total Equity
| 26.758 | 27.929 | 50.755 | 31.027 | 51.352 | 39.935 | 11.522 | 25.227 | 31.128 | 18.006 | 0.585 | 0.496 |
| Total Liabilities & Shareholders Equity
| 38.68 | 95.49 | 153.56 | 105.01 | 141.097 | 141.341 | 103.876 | 35.063 | 33.95 | 21.884 | 7.277 | 0 |